Literature DB >> 25862088

Aberrant high frequency oscillations recorded in the rat nucleus accumbens in the methylazoxymethanol acetate neurodevelopmental model of schizophrenia.

Sailaja A Goda1, Maciej Olszewski1, Joanna Piasecka1, Karolina Rejniak1, Miles A Whittington2, Stefan Kasicki1, Mark J Hunt3.   

Abstract

BACKGROUND: Altered activity of the nucleus accumbens (NAc) is thought to be a core feature of schizophrenia and animal models of the disease. Abnormal high frequency oscillations (HFO) in the rat NAc have been associated with pharmacological models of schizophrenia, in particular the N-methyl-d-aspartate receptor (NMDAR) hypofunction model. Here, we tested the hypothesis that abnormal HFO are also associated with a neurodevelopmental rat model.
METHODS: Using prenatal administration of the mitotoxin methylazoxymethanol acetate (MAM) we obtained the offspring MAM rats. Adult MAM and Sham rats were implanted with electrodes, for local field potential recordings, in the NAc.
RESULTS: Spontaneous HFO (spHFO) in MAM rats were characterized by increased power and frequency relative to Sham rats. MK801 dose-dependently increased the power of HFO in both groups. However, the dose-dependent increase in HFO frequency found in Sham rats was occluded in MAM rats. The antipsychotic compound, clozapine reduced the frequency of HFO which was similar in both MAM and Sham rats. Further, HFO were modulated in a similar manner by delta oscillations in both MAM and Sham rats.
CONCLUSION: Together these findings suggest that increased HFO frequency represents an important feature in certain animal models of schizophrenia. These findings support the hypothesis that altered functioning of the NAc is a core feature in animal models of schizophrenia.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clozapine; High frequency oscillations; MAM rat model; NMDAR antagonists; Schizophrenia

Mesh:

Substances:

Year:  2015        PMID: 25862088     DOI: 10.1016/j.pnpbp.2015.03.016

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  5 in total

1.  GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for Schizophrenia.

Authors:  Kiran Sapkota; Zhihao Mao; Paul Synowicki; Dillon Lieber; Meng Liu; Tsuneya Ikezu; Vivek Gautam; Daniel T Monaghan
Journal:  J Pharmacol Exp Ther       Date:  2015-12-16       Impact factor: 4.030

2.  Altered cortico-striatal crosstalk underlies object recognition memory deficits in the sub-chronic phencyclidine model of schizophrenia.

Authors:  Aman Asif-Malik; Daniel Dautan; Andrew M J Young; Todor V Gerdjikov
Journal:  Brain Struct Funct       Date:  2017-03-14       Impact factor: 3.270

3.  Cannabis Vapor Exposure Alters Neural Circuit Oscillatory Activity in a Neurodevelopmental Model of Schizophrenia: Exploring the Differential Impact of Cannabis Constituents.

Authors:  Bryan W Jenkins; Shoshana Buckhalter; Melissa L Perreault; Jibran Y Khokhar
Journal:  Schizophr Bull Open       Date:  2021-11-20

4.  Activity-State Dependent Reversal of Ketamine-Induced Resting State EEG Effects by Clozapine and Naltrexone in the Freely Moving Rat.

Authors:  Christien Bowman; Ulrike Richter; Christopher R Jones; Claus Agerskov; Kjartan Frisch Herrik
Journal:  Front Psychiatry       Date:  2022-01-27       Impact factor: 4.157

5.  Nasal respiration is necessary for ketamine-dependent high frequency network oscillations and behavioral hyperactivity in rats.

Authors:  Jacek Wróbel; Władysław Średniawa; Gabriela Jurkiewicz; Jarosław Żygierewicz; Daniel K Wójcik; Miles Adrian Whittington; Mark Jeremy Hunt
Journal:  Sci Rep       Date:  2020-11-04       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.